Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granulocyte-Colony Stimulating Factor for feeding tolerance in preterm infants
IRCT20180731040650N1Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Sep 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of granulocyte colony-stimulating factor, sponsored by Babol University of Medical Sciences. Started Sep 2018; status: completed.
02
Drugs
granulocyte colony-stimulating factor
Beyond the preview
Go deeper on IRCT20180731040650N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180731040650N1.